Physician

Kyle Gerard Ulveling, M.D.

According to 2025 Medicare claims, Kyle Ulveling, M.D. (NPI: 1790906246) practices cardiology in the Ames, IA market, with the plurality of this provider's patient population coming from Story, IA. This provider's primary affiliated billing organization is CATHOLIC HEALTH INITIATIVES-IOWA CORP (NPI: 1629301684; TIN: 420680448) and primary practice location at 50010-8771. Ulveling is affiliated with the MercyOne ACO III (ACO ID: A3380), Avera Prairie View ACO (ACO ID: A4692), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), Main Street Rural Health Dogwood ACO LLC (ACO ID: A5421), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Ulveling's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,701 traditional Medicare patients, billed 13,760 HCPCS/CPT codes, and received $331,367 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 8,101 prescription claims across 1,266 beneficiaries totaling $939,354 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 11 claims. Open Payments data shows 9 records totaling $153. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $217,661 to $939,354. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,427	5,486	$340,007
2016	1,345	5,180	$318,564
2017	1,474	5,043	$370,066
2018	1,535	4,811	$358,766
2019	1,599	5,564	$393,758
2020	1,217	3,710	$256,550
2021	1,241	3,863	$281,930
2022	1,321	3,800	$263,598
2023	1,424	12,317	$328,129
2024	1,701	13,760	$331,367

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	658	5,575	$217,661
2016	703	6,868	$435,534
2017	725	6,931	$432,100
2018	804	7,805	$532,550
2019	829	7,984	$571,425
2020	880	7,995	$739,348
2021	855	7,566	$720,859
2022	883	7,372	$889,766
2023	975	7,206	$932,652
2024	1,266	8,101	$939,354

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$691
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	494	505	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	653	774	$80
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	149	153	$46
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	492	541	$8
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	142	144	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	713	27,157	$519,645
Entresto	Sacubitril/Valsartan	142	4,935	$107,396
Xarelto	Rivaroxaban	112	5,827	$104,734
Repatha Sureclick	Evolocumab	56	1,932	$37,810
Jardiance	Empagliflozin	33	1,410	$28,242

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$153	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kyle Gerard Ulveling, M.D.?

Tedicare shows public-source Medicare data for Kyle Gerard Ulveling, M.D. (NPI 1790906246), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kyle Gerard Ulveling, M.D. have ACO affiliation data?

Kyle Gerard Ulveling, M.D. is shown with ACO affiliation data for MercyOne ACO III (MSSP, ACO ID A3380), Avera Prairie View ACO (MSSP, ACO ID A4692), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), Main Street Rural Health Dogwood ACO LLC (MSSP, ACO ID A5421), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Kyle Gerard Ulveling, M.D.?

Kyle Gerard Ulveling, M.D. is linked to CATHOLIC HEALTH INITIATIVES-IOWA CORP (billing NPI 1629301684) in the available physician profile data.

Does Kyle Gerard Ulveling, M.D. have Open Payments data?

Kyle Gerard Ulveling, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.